首页> 美国卫生研究院文献>other >Health-related quality of life in patients who develop bronchiolitis obliterans syndrome following allo-SCT
【2h】

Health-related quality of life in patients who develop bronchiolitis obliterans syndrome following allo-SCT

机译:异源SCT后发展为闭塞性细支气管炎综合征患者的健康相关生活质量

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Bronchiolitis obliterans syndrome (BOS) remains an important complication following allo-SCT. The development of this condition portends a higher morbidity and mortality but the effect on heath-related quality of life (HRQL) is unknown. The aim of this study was to determine whether the development of BOS impacted HRQL compared with patients without BOS. This Institutional Review Board-approved prospective study analyzed 126 patients who underwent allo-SCT at our institution. Patients were administered three HRQL survey tools (SF-36, European Organization for Research and Treatment of Cancer QLQ-c30 and St George Respiratory Questionnaire (SGRQ)) before transplant and then again at 6 months, 1 year and 2 years after transplant. Patients were analyzed in three groups determined by highest chronic GVHD (cGVHD) severity and BOS status. Overall, our study group had improving HRQL after transplant when measured over time, measured by the SF-36 with stable HRQL, when measured by the SGRQ total score and QLQ-c30. Patients that developed BOS had significantly worse HRQL scores measured by the SGRQ and the SF-36 physical composite score. This difference was not explained by the severity of cGVHD that patients with BOS developed.
机译:闭塞性细支气管炎综合征(BOS)仍然是异源SCT后的重要并发症。这种病的发展预示着更高的发病率和死亡率,但是对健康相关生活质量(HRQL)的影响尚不清楚。这项研究的目的是确定与没有BOS的患者相比,BOS的发展是否会影响HRQL。这项经过机构审查委员会批准的前瞻性研究分析了我们机构中接受allo-SCT的126例患者。患者在移植前接受了三种HRQL调查工具(SF-36,欧洲癌症研究和治疗组织QLQ-c30和圣乔治呼吸问卷(SGRQ)),然后在移植后的6个月,1年和2年再次使用。根据最高慢性GVHD(cGVHD)严重程度和BOS状态确定了三组患者。总体而言,我们的研究组随时间推移(通过SF-36进行测量)与HRQL稳定(通过SGRQ总分和QLQ-c30进行测量)相比,移植后的HRQL有所改善。通过SGRQ和SF-36物理综合评分测得的BOS患者HRQL评分明显较差。 BOS患者发生的cGVHD的严重程度不能解释这种差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号